Womens Imaging: Page 12

AI assistance improves CHD detection on prenatal ultrasound
By Amerigo Allegretto
AI boosts detection of major congenital heart defects (CHDs) on prenatal ultrasound, suggest findings presented at the Annual Pregnancy Meeting of the SMFM.
January 31, 2025
Smfm Ultrasound Ai Fetal Thumbnail
Ultrafast MRI exam bests standard MRI for classifying breast cancers
By Amerigo Allegretto
An ultrafast MRI-based radiomics exam performs just as well as standard MRI and isn’t dependent on radiologist experience.
January 28, 2025
Ultrafast and standard MRI in a 30-year-old woman with triple-negative invasive ductal carcinoma. (A) Ultrafast MRI taken 16.8 seconds after contrast agent injection. (B) Standard MRI taken 58.8 seconds after contrast agent injection. Both images show an oval-shaped, irregular marginated, rim-enhancing mass in the left outer breast. For 3D tumor segmentation, the entire enhanced tumor margins were drawn from top to bottom of each tumor in axial views of U2 phase postcontrast ultrafast MRI and the initial phase postcontrast standard MRI. Among the 14 ultrafast images, U1 is the first phase in which the signal intensity of the hotspot region of interest of the tumor is 10% higher than the average signal intensity of unenhanced images. U2 is the immediate next phase of U1 and the well-established tumor enhancement time.
Triple-negative breast cancers impact female populations differently
By Amerigo Allegretto
Despite overall breast cancer rate increases, women of varying race and ethnicity experience disproportionately higher increases.
January 24, 2025
Breast Cancer Cell2 Social
Current topics in mammography
By Sandy Coffta
Sandy Coffta of Healthcare Administrative Partners discusses changes in reporting and reimbursement for mammography exams.
January 17, 2025
Coffta Sandy Thumbnail
CEM has slightly higher mean glandular dose than DBT, mammography
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) has a slightly higher mean glandular dose than other breast imaging modalities.
January 16, 2025
Contrast Injector
POCUS useful for diagnosis of retained conception tissue
By Amerigo Allegretto
Point-of-care ultrasound (POCUS) can be a useful tool for diagnosing the presence of retained conception tissue.
January 15, 2025
Ultrasound Portable
CEM-, radiomics-based models predict breast biopsy outcomes
By Amerigo Allegretto
Machine-learning models combining features from radiomics and contrast-enhanced mammography (CEM) can predict breast biopsy outcomes in women.
January 13, 2025
Mammo Reading Social
Genetic testing, risk assessment tied to more breast MRI uptake
By Amerigo Allegretto
Women with high-risk pathological variants for breast cancer as identified by genetic testing and risk assessment are more likely to undergo breast MRI.
January 13, 2025
Mri Breast 400
DBT on par with mammography for imaging referred women
By Amerigo Allegretto
Digital breast tomosynthesis (DBT) has a diagnostic accuracy comparable to digital mammography for women referred for breast imaging.
January 10, 2025
Breast Dbt Social
AI-supported mammography is safe and effective in real-world settings
By Amerigo Allegretto
A prospective study found that AI-supported mammography screening is effective in a nationwide, real-world setting.
January 8, 2025
Breast Mammo Computer 400 (1)
Women with BRCA1/2 germline mutations are often denied breast MRI
By Kate Madden Yee
Women with BRCA1/2 germline mutations are often denied breast MRI -- despite the fact that the exam is recommended for this population.
January 3, 2025
Mri Breast Cancer
Starting breast cancer screening at 40 is more cost-effective
By Amerigo Allegretto
Starting breast cancer screening at age 40 is tied to improved patient outcomes and reduced healthcare spending on treatment.
January 3, 2025
Women Cancer Patient
Previous Page
Page 12 of 691
Next Page